Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
295
NCT02771509
Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass
Phase: Phase 2
Role: Collaborator
Start: Feb 24, 2017
Completion: Aug 31, 2021
NCT04538040
Bictegravir/Emtricitabine/Tenofovir Alafenide Plus Doravirine
Phase: Phase 4
Role: Lead Sponsor
Start: Dec 19, 2019
Completion: Nov 11, 2021